Current trends affecting self-funded healthcare plans

Business Insurance
4 followers
7 Video Views·Sep 8, 2025
Insurance Business TV sits down with Tara Krauss, President of Accident & Health at QBE North America, to unpack the company’s latest market report.
From rising medical stop-loss claims to specialty pharmacy growth and challenges to building a healthier society, this episode explores the evolving dynamics of self-funded healthcare plans.
Hello everyone and welcome to the latest edition of Insurance Business TV as we delve into the
A&H market with QBE North America. The company has released its 2025 Accident and Health Market
Report which offers insights on current trends affecting self-funded health care plans.
Key topics include medical stop-loss claims trends, growth in the specialty pharmacy market
and factors hindering a healthier society. Well to discuss its findings and more we welcome
Tara Krause, President of Accident and Health at QBE North America. Tara, welcome to IBTV.
Paul, thanks for having me today.
So to kick things off, Tara, let's talk about medical stop-loss coverage.
What makes it an important part of a self-funded employer's benefit strategy?
Thanks Paul, I think that's a really important question and one that sometimes gets overlooked
in a self-funded plan. So self-insured plans really dominate the commercial market today.
Over 65% of health plans are self-insured and actually upwards of 85% of mid to large
employer groups, that's 500 plus self-insured. It's definitely the preferred option for employers
seeking to control costs and have the ability to customize their plans. Stop-loss is pretty common
for a self-insured plan for a number of reasons, growing increasingly important with today's
current claims trends. Nearly all small to mid-market self-insured plans will have stop-loss
but it's becoming even more prevalent with the large group market. We're seeing an increase in
both frequency and severity of claims in recent years, making stop-loss coverage really a wise
choice to protect the plan assets. In fact our claims trend study that we'll probably get into
a little bit today revealed that our million dollar claims have doubled in the last four
years time. So it's a really a great asset, a safety net for the self-insured plan.
Well you brought me newly to it there, let's talk a little bit about some of those key
findings from this year's report. What should brokers and employers be paying attention to?
Good question. I think it's important that they continue to explore cost-effective
point solution options, plan enhancements to mitigate those current claims trends
that we'll talk about today. The importance of increasing prevalence of disease is something
that we've been focusing a ton on. The proliferation of these one million dollar claims post the ACA,
specialty pharmaceuticals and the number of new approvals each year that drive those chronic
disease and some of those rare conditions that are out in the market now. The employers really
need to educate themselves and that's where we can rely on our brokers to focus and educate
the consumer. And of course the report highlights rising claims costs tied to cancer, circulatory
disease and premature births as well. So what's driving those trends and what are the implications
for benefit strategies and stop-loss coverage? There's a number of things driving the trends,
but I'd say for this question I'd focus on cancer, circulatory and some of those premature
birth claims and I can get into that a little bit. Cancer continues to be that kind of the elephant
in the room year over year in the healthcare space. It's the predominant driver of stop-loss
claims on our book of business and many of my competitors. It drives nearly a third to a fourth
of our full book of excess loss claims regardless of spec deductible. Outside of root cause,
the cost of these claims is largely driven by the treatment. These are really targeted and
expensive treatments, not like what we had seen 20 to 30 years ago where you had one diagnosis
and one treatment plan. There are a multitude of treatment plans depending on the type of tumor,
the staging of the tumor, the age of the individual and what comorbidities they might have.
Some of these targeted expensive therapies include CAR T-cells, immunotherapy, stem cell
transplants that used to be maybe third or fourth line of defense are now moving up to a first or
second line of defense in the treatment plan. These are cancers that might be getting treated
more aggressively at earlier stages because of the advanced staging of an initial diagnosis.
Certainly, we looked at and have continued to look at the impact of deferred care
as a result of the pandemic. A lot of people stayed home. They weren't getting a preventative
care. Cancer had the opportunity to progress to a further stage, ultimately getting more costly
treatments. Our book frequency, for example, we see about 21 neoplasm cancer-related claims for
every 10,000 employees on a health plan and the average of those claims is upwards of 375,000,
roughly 365 to be exact. Circulatory claims is another big one and something we did focus on a
lot this year in our review. This is anything related to heart failure, AFib, valve disorders,
pulmonary disease. These claims are largely driven by chronic disease, comorbidities,
things like diabetes, obesity, hypertension. Healthcare-related costs to these conditions
is expected to triple in the next 30 years. There has to be a ton of focus in the healthcare space
on these conditions. The frequency in our claims has risen about 60% post-COVID. Sedentary
lifestyles, the American lifestyle has certainly contributed. Last, you had mentioned premature
births. We haven't really seen an increased incidence of premature births, but we've really
observed an increase in pre-term births that have congenital anomalies. That increases the
severity of the claim because there's earlier and more aggressive interventions with that type of
premature birth. Okay, and the report also talks about the impact of poor societal health as well.
So, can you share some more insights on that topic and how it might be impacting claims?
Sure, Paul. So, reinsurers don't tend to take too much look at what's driving these claims,
we're reimbursing them. And we felt it was important to take a look at really what is
driving it from a societal perspective, especially with the focus of the current administration.
So, the market is definitely seeing an increase in cancer diagnosis across the board, but
specifically breast, colon, pancreas, lung, and younger age, more aggressive stage. A higher
diagnosis rate in women, specifically younger women under 50 related to breast and thyroid.
This is really less about genetics and more about environmental and lifestyle factors.
Certainly, better detections at play, genetic factors and your life factor into your lifetime
risk of cancer. But the trends are really pointing at environmental and lifestyle as being the
driving factors of what's causing these alarming trends. 90 to 95% of cancers are caused by what
we consider a modifiable factor that includes everything from tobacco use, alcohol intake,
living a sedentary lifestyle, diet and obesity. With over 50% of our diet in the US being processed
and 85% of what's on the shelves having some questionable ingredients that could be
contributing to chronic disease, inflammation in the body, our food supply, infectious agents,
and certainly even the healthiest of crops being sprayed with pesticides that have some alarming
chemicals that are getting attention currently in the US. One study I read suggests that the
incidence of early onset cancer is expected to increase 50% globally in the coming years. So,
it is something that we as a society and those in the healthcare space should really be calling
attention to and focusing on. QE, of course, recently expanded its offerings to Taft-Hartley
and a multi-employer health plan. So, what makes this market unique and how is QBE addressing the
needs? Sure. We're really excited to be in this space and have this new offering. We've got a
great team. The labour unions are really uniquely positioned to handle the management of claims
due to both those relationships. They're a very relationship-driven cohort and they have strong
alignment with their key constituents, those that are leveraging the plan. 95% of members
on a union plan have access to healthcare as opposed to 65% in the general commercial market,
and those individuals are seven times more likely to seek regular healthcare visits with their
primary care. Obviously, seeking healthcare visits, you get the screening and the prevention
and likely to get earlier detection on anything going on or direction on what you might need
to mitigate to prevent long-time risks. Unions tend to also implement from a plan-controlled
basis better utilization management. They implement things like reference-based pricing
and centres of excellence to manage their costs. They're really well-managed plans.
They have strong governance. Speaking from a staff-loss insurance partner, we see higher
close ratios on the business we quote, lower claims, and an incredibly loyal customer base.
So once you have a union customer, they tend to stick with you over the long term.
And given what the report highlights, what advice would you give to brokers when it comes to
helping clients plan for the next year? From a stop-loss perspective, I'd ask that they just
continue to share their knowledge with the broader customer base on educating them on,
you know, the lifestyle factor stuff that we talked about, because we tend to kind of sit
back and I think that's something we all need to start leaning into and to really impact change.
A solid PBM management plan, it all starts with that. Have a judicious focus on a transparent
vendor in that space. There's a real lack of transparency with some of the big players.
So focusing on reducing waste, how are rebates handled, site of care controls are in place.
As far as the reinsurance renewals, educating the employer groups on what leverage trend is
and how important it is, you know, even slight modifications, increases to the employers,
what we call their specific deductible, year over year helps to mitigate their renewal increases.
Partnering certainly with a financially sound carrier that shows up at time of claim, really,
it only takes one bad claim experience to lose a long-term client. So credibility,
a-rated, responsive and service-led team, I think is critically important.
Yeah, great advice and obviously a lot to gauge from the report as well. If anyone wants to know
more, Tara, where can they find it? Sure, they can go to the QBE website, qbe.com,
and search for the A&H page and we've got a copy of the report there.
Excellent, and once you've finished there, well, make sure you come back to us too.
We'll be waiting to see you next time, right here on Insurance Business TV.
